Newsinc24 Team 
India and the UK on Wednesday launched a virtual vaccines hub to facilitate the delivery of vaccines for Covid-19 and other viruses and to foster cooperation between experts on clinical trials and regulatory approvals. Visiting UK foreign secretary Dominic Raab announced the launch of the hub, aimed at protecting people in both countries by enhancing cooperation on the development and distribution of Covid-19 vaccines and better aligning the international regulation of vaccines.
The hub will also foster partnerships to develop innovation “moonshots” that can define vaccine delivery over the next decade. It will enable British and Indian experts to share knowledge on clinical trials and regulatory approvals and get vaccines to people who need them most in a safe, secure and energy-efficient manner. The Serum Institute of India plans to roll-out more than a billion doses of the vaccine developed by Oxford University and AstraZeneca. Unlike other doses, it can be stored at normal fridge temperatures, making it easier and cheaper to produce, store and distribute.
Raab said, “This Serum Institute and Oxford University partnership demonstrates the UK-India relationship at its best – a vaccine developed in the UK and made in India, drawing our brightest minds together to save lives as a global force for good. India and the UK also announced a new memorandum of understanding between the Central Drugs Standard Control Organisation (CDSCO) and the UK Medicines and Healthcare Products Regulatory Agency on more frequent discussions on bilateral vaccine and pharmaceutical regulations, improving standards and sharing information to control the trade of unlicensed products.
Raab, who met Prime Minister Narendra Modi on Wednesday to discuss a 10-year roadmap for bilateral cooperation and collaboration on the Covid-19 vaccine, praised the Indian government’s commitment to eq ndia supplies more than 50 per cent of the world’s vaccines and 25 per cent of the UK National Health Service’s generic drugs. Closer UK-India cooperation on medicines and vaccines approvals will ensure speedy access for the UK to Indian-produced pharmaceuticals and help safeguard supplies to the NHS.uitable global access to vaccines. He also visited a Delhi health clinic where the AstraZeneca vaccine will be administered.
Related Items
DRDO & IAF successfully conduct maiden trial of indigenous TARA glide weapon
India-EU trade pact to impact two billion people globally
India, Vietnam can play pivotal role in global supply chain: To Lam